• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症免疫疗法的最新进展,重点是疫苗。

Recent advances in cancer immunotherapy with an emphasis on vaccines.

作者信息

Cavallo Federica, Forni Guido

机构信息

Molecular Biotechnology Center, Department of Clinical and Biological Sciences, University of Torino, Via Nizza, 52 I-10126 Torino, Italy.

出版信息

Expert Rev Vaccines. 2009 Jan;8(1):25-8. doi: 10.1586/14760584.8.1.25.

DOI:10.1586/14760584.8.1.25
PMID:19093768
Abstract

Recent Advances in Cancer Immunotherapy with an Emphasis on Vaccines was the first meeting organized by the European Society of Cancer Immunology and Immunotherapy and Progress in Vaccine against Cancer, in collaboration with the Institute of Biological Research and Biotechnology of the National Hellenic Research Foundation, in a joint effort towards the setting up of a new generation of cancer vaccines. The main topics of the meeting included: the role of the tumor microenvironment in protecting the tumor from immune attack; differences in immunotherapy outcome in hematological malignancies versus solid tumors; rationale of multi-epitope vaccines; Treg cell elimination/inactivation, tumor stroma destruction, angiogenesis inhibition and the potentiality of 'preventive' vaccination in breast, colon, prostate and ovarian cancer in the early stages and during the 'wait-and-see' period. The ninth Progress in Vaccines against Cancer meeting will be held in Sofia, Bulgaria, 8-10 October 2009, at the Hilton Hotel.

摘要

《癌症免疫疗法最新进展:聚焦疫苗》是由欧洲癌症免疫与免疫疗法协会以及抗癌疫苗进展组织的首次会议,此次会议与希腊国家研究基金会生物研究与生物技术研究所合作,共同致力于研发新一代癌症疫苗。会议的主要议题包括:肿瘤微环境在保护肿瘤免受免疫攻击中的作用;血液系统恶性肿瘤与实体瘤免疫治疗效果的差异;多表位疫苗的原理;调节性T细胞的清除/失活、肿瘤基质破坏、血管生成抑制以及在乳腺癌、结肠癌、前列腺癌和卵巢癌早期及“观察等待”期进行“预防性”疫苗接种的潜力。第九届抗癌疫苗进展会议将于2009年10月8日至10日在保加利亚索非亚的希尔顿酒店举行。

相似文献

1
Recent advances in cancer immunotherapy with an emphasis on vaccines.癌症免疫疗法的最新进展,重点是疫苗。
Expert Rev Vaccines. 2009 Jan;8(1):25-8. doi: 10.1586/14760584.8.1.25.
2
ESCII-PIVAC meeting "Recent advances in cancer immunotherapy with an emphasis on cancer vaccines" held in Athens, 9-11 October 2008.欧洲癌症免疫治疗学会-个人化免疫疫苗联合会议“癌症免疫治疗的最新进展,重点关注癌症疫苗”于2008年10月9日至11日在雅典举行。
Cancer Immunol Immunother. 2010 Apr;59(4):635-40. doi: 10.1007/s00262-009-0664-0. Epub 2009 Jan 30.
3
Ninth international conference on progress in vaccination against cancer (PIVAC 9), 8-10 October 2009, Sofia, Bulgaria.第九届癌症疫苗接种进展国际会议(PIVAC 9),2009年10月8日至10日,保加利亚索非亚
Cancer Immunol Immunother. 2010 Oct;59(10):1569-72. doi: 10.1007/s00262-010-0838-9. Epub 2010 Mar 10.
4
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31Annual Meeting of the Society for Immunotherapy of Cancer, 2016.正在研发中的新型癌症免疫治疗药物:来自 2016 年癌症免疫治疗学会第 31 届年会相关项目的报告。
J Immunother Cancer. 2017 Jun 20;5:50. doi: 10.1186/s40425-017-0253-2. eCollection 2017.
5
CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.2014年癌症免疫治疗进展:癌症免疫治疗协会第12届年会报告——2014年5月6 - 8日于德国美因茨召开
Hum Vaccin Immunother. 2014;10(10):3090-100. doi: 10.4161/hv.29767.
6
[Immunotherapy of solid tumor: perspectives on vaccine and cell therapy].实体瘤的免疫治疗:疫苗与细胞治疗的前景
Nihon Rinsho. 2012 Dec;70(12):2043-50.
7
Cancer immunotherapy for metastasis: past, present and future.癌症免疫疗法治疗转移瘤:过去、现在与未来。
Brief Funct Genomics. 2019 Mar 22;18(2):140-146. doi: 10.1093/bfgp/ely022.
8
Recent advances in cancer immunology and immunology-based anticancer therapies.癌症免疫学和基于免疫学的抗癌疗法的最新进展。
Biomed Pharmacother. 2017 Dec;96:1491-1500. doi: 10.1016/j.biopha.2017.11.126. Epub 2017 Dec 2.
9
Review of the 25th annual scientific meeting of the International Society for Biological Therapy of Cancer.第 25 届国际癌症生物治疗学会年会综述。
J Transl Med. 2011 May 12;9:60. doi: 10.1186/1479-5876-9-60.
10
Recent advances and current challenges in tumor immunology and immunotherapy.肿瘤免疫学与免疫治疗的最新进展及当前挑战
Mol Ther. 2007 Jun;15(6):1065-71. doi: 10.1038/sj.mt.6300138. Epub 2007 Mar 20.

引用本文的文献

1
Booster immunizations with DNA plasmids encoding HER-2/neu prevent spontaneous mammary cancer in HER-2/neu transgenic mice over life span.用编码 HER-2/neu 的 DNA 质粒进行增强免疫接种可预防 HER-2/neu 转基因小鼠一生中自发发生的乳腺癌。
Sci Rep. 2017 Jun 8;7(1):3078. doi: 10.1038/s41598-017-03286-8.
2
In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging.体内电穿孔恢复了针对衰老的 HER-2/neu 的 DNA 疫苗接种的低效率。
Cancer Immunol Immunother. 2012 Mar;61(3):363-71. doi: 10.1007/s00262-011-1107-2. Epub 2011 Sep 16.